KBP-336

DRUG2 trials

Sponsors

KeyBioscience S.A., KeyBioscience AG

Conditions

Knee osteoarthritisObesityOsteoarthritis in the Knee

Phase 2

A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of KBP-336 as an Adjunct to Diet and Exercise in Obese Individuals with Osteoarthritis of the Knee

Active, not recruitingCTIS2024-517264-27-00

KeyBioscience S.A.Knee osteoarthritis, Obesity

Start: 2024-12-13Target: 495Updated: 2025-10-09

Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis

RecruitingNCT06833749

KeyBioscience AGObesity, Osteoarthritis in the Knee

Start: 2025-01-28End: 2026-12-31Target: 600Updated: 2025-02-19